119 results on '"He, Qiaojun"'
Search Results
2. The role of Tim-3 blockade in the tumor immune microenvironment beyond T cells
3. Isorhapontigenin alleviates acetaminophen-induced liver injury by promoting fatty acid oxidation
4. Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement
5. Macrophage senescence in health and diseases
6. Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks
7. Cediranib enhances the transcription of MHC-I by upregulating IRF-1
8. Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis
9. Strategies to synergize PD-1/PD-L1 targeted cancer immunotherapies to enhance antitumor responses in ovarian cancer
10. Crizotinib induces pulmonary toxicity by blocking autophagy flux in alveolar epithelial cells
11. The palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML
12. Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
13. Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
14. Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
15. AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells
16. The impact of lipids on the cancer–immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy
17. JAK-STAT signaling as an ARDS therapeutic target: Status and future trends
18. Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer
19. Deubiquitinating enzymes: Promising targets for drug resistance
20. Design, synthesis and biological evaluation of new dihydropyridine derivatives as PD-L1 degraders for enhancing antitumor immunity
21. Targeting innate immune responses to attenuate acetaminophen-induced hepatotoxicity
22. Tackling drug resistance in ovarian cancer with epigenetic targeted drugs
23. Identifying chronic alcoholism drug disulfiram as a potent DJ-1 inhibitor for cancer therapeutics
24. Decreased HMGB1 expression contributed to cutaneous toxicity caused by lapatinib
25. Protective effects of six different pectic polysaccharides on DSS-induced IBD in mice
26. Progress and perspective of organoid technology in cancer-related translational medicine
27. The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies
28. Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
29. Design, synthesis, and biological evaluation of quinazoline derivatives with covalent reversible warheads as potential FGFR4 inhibitors
30. WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
31. Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor
32. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
33. Design, synthesis and biological evaluation of quinazoline derivatives as potent and selective FGFR4 inhibitors
34. Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
35. Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation
36. Anti-inflammation effects of highly purified low-Mw RG-I pectins on LPS-activated macrophages
37. Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
38. One therapeutic approach for triple-negative breast cancer: Checkpoint kinase 1 inhibitor AZD7762 combination with neoadjuvant carboplatin
39. Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy
40. Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma
41. Recent advance of peptide-based molecules and nonpeptidic small-molecules modulating PD-1/PD-L1 protein-protein interaction or targeting PD-L1 protein degradation
42. Regulation of p53 stability as a therapeutic strategy for cancer
43. Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
44. Effects of prepubertal exposure to forchlorfenuron through prenatal and postnatal gavage administration in developing Sprague-Dawley rats
45. Structure-activity relationship of Citrus segment membrane RG-I pectin against Galectin-3: The galactan is not the only important factor
46. PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer
47. 6-Dithio-2′-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase
48. ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression
49. Targeting post-translational modification of transcription factors as cancer therapy
50. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.